(188 days)
Not Found
Not Found
No
The device is described as a passive electrode, which serves as an interface and does not perform any processing or analysis that would typically involve AI/ML. The summary explicitly states "Mentions AI, DNN, or ML: Not Found".
No.
The device description states that the electrodes are "passive devices serving as an interface between a patient's skin and a neurostimulation device", indicating they are accessories to a therapeutic device rather than therapeutic devices themselves.
No
Explanation: The provided text states that the Lifecare electrodes are "passive devices serving as an interface between a patient's skin and a neurostimulation device." They are used with neurostimulation devices, which would deliver the therapy, but the electrodes themselves do not perform diagnostic functions. Their purpose is to facilitate the delivery of stimulation, not to diagnose a condition.
No
The device description explicitly states that the device is a physical electrode, which is a hardware component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the electrodes are for use with transcutaneous neurostimulation devices, serving as an interface between the skin and the device. This is a direct interaction with the patient's body for therapeutic purposes (neurostimulation).
- IVD Definition: In vitro diagnostics are devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. This device does not involve the examination of such specimens.
- Device Description: The description reinforces that these are passive devices acting as an interface with the skin.
Therefore, the Lifecare electrodes described are medical devices, but they fall under the category of devices used for direct patient treatment or interaction, not for in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
The Lifecare electrodes are intended to be used with transcutaneous neurostimulation devices. Some common types of neurostimulation devices include, but are not limited to, TENS devices and powered muscle stimulation devices. Transcutaneous neurostimulation electrodes are passive devices serving as an interface between a patinet's skin and a neurostimulation device.
Product codes
GXY
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.1320 Cutaneous electrode.
(a)
Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, enclosed within a circular border. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is written around the border of the circle.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 0 5 2002
Mr. Robert Tu Everyway Medical Instruments Co., Ltd. 3 Fl., No. 5, Lane 155, Peishen Rd., Sec. 3 Shen Keng Hsiang, Taipei Hsien 222, Taiwan, R.O.C.
Re: K012463
Trade/Device Name: Lifecare: 5 x 5 CM Square, 4 x 4 CM Square, 5 CM Round, 7.5 CM Round, 4 x 6 CM Oval, 5 x 10 CM Oval, 4 x 8 CM Rectangle,
5 x 10 CM Rectangle Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous electrode Regulatory Class: Class II Product Code: GXY Dated: November 8, 2001 Received: November 13, 2001
Dear Mr. Tu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the
1
Page 2 - Mr. Tu
quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Mark N. Millano
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
510(k) Number (if known): K012463
Device Name:__Lifecare Neurostimulation Electrode
Indications For Use:
The Lifecare electrodes are intended to be used with transcutaneous neurostimulation devices. Some common types of neurostimulation devices include, but are not limited to, TENS devices and powered muscle stimulation devices. Transcutaneous neurostimulation electrodes are passive devices serving as an interface between a patinet's skin and a neurostimulation device.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
KO12463
Marlis N. Millhurn
(Optional Format 3-10-98)
Division Sign-Off) Division of General, Restorative and Neurological Devices
510(k) Number -